Viewing Study NCT00840333


Ignite Creation Date: 2025-12-25 @ 2:41 AM
Ignite Modification Date: 2025-12-26 @ 7:05 PM
Study NCT ID: NCT00840333
Status: COMPLETED
Last Update Posted: 2024-12-04
First Post: 2009-02-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: "Safety, Tolerability and Pharmacokinetics of MP-376 Administered for 14 Days to Stable Pediatric (CF) Patients"
Sponsor: Amgen
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2009-04
Start Date Type: None
Primary Completion Date: 2009-12
Primary Completion Date Type: ACTUAL
Completion Date: 2009-12
Completion Date Type: ACTUAL
First Submit Date: 2009-02-05
First Submit QC Date: None
Study First Post Date: 2009-02-10
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-12-02
Last Update Post Date: 2024-12-04
Last Update Post Date Type: ACTUAL